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A B S T R A C T
Long-term exposure to hypercholesterolemia induces the development of skin xanthoma's characterized by the
accumulation of lipid-laden foam cells in humans and in mice. Early skin changes in response to hypercholes-
terolemia are however unknown. In this study, we investigated the skin lipid composition and associated barrier
function in young adult low-density lipoprotein receptor knockout (LDLR−/−) and apolipoprotein E knockout
(APOE−/−) mice, two commonly used hypercholesterolemic mouse models characterized by the accumulation
of apolipoprotein B containing lipoproteins. No differences were observed on cholesterol content in the epi-
dermis in LDLR−/− mice nor in the more extremely hypercholesterolemic APOE−/− mice. Interestingly, the free
fatty acid profile in the APOE−/− epidermis shifted towards shorter and unsaturated chains. Genes involved in
the synthesis of cholesterol and fatty acids were downregulated in APOE−/− skin suggesting a compensation for
the higher influx of plasma lipids, most probably as cholesteryl esters. Importantly, in vivo transepidermal water
loss and permeability studies with murine lipid model membranes revealed that the lipid composition of the
APOE−/− skin resulted in a reduced skin barrier function. In conclusion, severe hypercholesterolemia associated
with increased apolipoprotein B containing lipoproteins affects the epidermal lipid composition and its pro-
tective barrier.
1. Introduction
Patients suffering from familial hypercholesterolemia often present
mutations in the low-density lipoprotein receptor (LDLR) or other
proteins (e.g. apolipoprotein E - apoE) that result in increased circu-
lating levels of low-density lipoprotein and a higher risk of developing
cardiovascular diseases [1–3]. Interestingly, these patients are also re-
ported to develop skin xanthoma's filled with cholesterol-laden mac-
rophages [4,5]. Lipid-lowering therapy with statins is the main choice
of treatment for hypercholesterolemic patients [1,4]. However, in some
cases statin treatment is not sufficient to reverse the skin phenotypes
[3,5].
Hypercholesterolemia has been extensively studied using LDLR
knockout (LDLR−/−) and APOE knockout (APOE−/−) mice. Both LDLR
and apoE play an essential role in the clearance of apolipoprotein B and
apoE containing lipoproteins from the circulation by the liver [6,7]. In
the absence of a functional LDLR, the clearance of apolipoprotein B and
apoE containing lipoproteins is impaired leading to accumulation of
these particles in the plasma. However, as apoE containing lipoproteins
are also cleared by LDLR-related protein 1 (LRP1), LDLR−/− mice de-
velop a mild hypercholesterolemia on a regular chow diet or severe
hypercholesterolemia when fed a high fat/high cholesterol diet [6,7].
APOE−/− mice, on the other hand, develop a more severe hypercho-
lesterolemic phenotype on chow diet as the lipoprotein clearance by
both the LDLR and LRP1 is impaired [6,7].
Similarly to hypercholesterolemic patients, xanthoma's have also
been described in the skin of LDLR−/− mice and APOE−/− mice. On a
low-fat diet the morphology of the skin of young adult LDLR−/− and
APOE−/− mice is comparable to the wild-type (WT) control of similar
age with no signs of inflammation or lipid deposits [8–11]. However, on
a high fat/high cholesterol diet both LDLR−/− mice and APOE−/− mice
showed accumulation of fat droplets and inflammatory infiltrates in
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their skin [10–12]. Furthermore, aging of APOE−/− mice fed low-fat
diet exhibited skin phenotypes characterized by skin thinning, hair
follicle loss and premature greying of the hair accompanied by impaired
hair regeneration, which appeared earlier than reported for WT con-
trols [13,14]. Also, these age-related skin changes can be accelerated
when APOE−/− mice received high fat/high cholesterol diet [13].
The skin naturally functions as a barrier protecting the body from
excessive water and electrolyte loss and permeation of harmful agents
and pathogens. This protective function is mostly performed by cor-
neocytes and an extracellular lipid domain present in the outermost
layer of the epidermis, the stratum corneum (SC) [15]. The SC lipid
domain mainly comprises cholesterol, ceramides (CERs) and free fatty
acids (FFAs), which are primarily synthesized by keratinocytes during
their differentiation process [16]. In addition to local lipid synthesis,
keratinocytes express receptors involved in the uptake of lipids from
plasma, (e.g. LDLR, scavenger receptor class B member I and cluster of
differentiation 36) via which plasma lipids likely enter the skin and can
be detected in the epidermis. [17–19].
Despite the crucial role of lipids in the skin barrier, the early con-
sequences of an impaired metabolism of apolipoprotein B and apoE
containing lipoproteins to the skin lipid composition and barrier func-
tion are unknown. In this study we compared young adult LDL−/− mice
and APOE−/− mice with WT controls of the same age and genetic
background to specifically analyze the effects of hypercholesterolemia
on skin morphology, lipid composition and organization, and barrier
functionality prior to the development of inflammatory phenotypes as
described for high fat/high cholesterol diets and aging.
2. Materials and methods
2.1. Chemicals
Manufacture's details regarding the chemicals used in these studies
are available in the online supplementary information (Appendix A).
2.2. Animals
16–18weeks old female WT, homozygous LDLR−/− and homo-
zygous APOE−/− mice (obtained from The Jackson laboratory and bred
at the Gorlaeus laboratories) all on a C57BL/6 background were kept
under standard laboratory conditions (20 °C and light cycle of 12 h
light/12 h dark) with water and standard low fat chow diet ad libitum
(Rat and Mouse No.3 breeding diet, Special Diets Services, United
Kingdom) and not fasted prior sacrifice. All experiments were per-
formed in accordance with National guidelines and approved by the
Ethics Committee for Animals Experiments of Leiden University. The
mice were anesthetized for retro-orbital bleeding (70mg/kg body
weight xylazine, 1.8 mg/kg body weight atropine, 350mg/kg body
weight ketamine) and shaving of the back skin followed by perfusion
with phosphate buffered saline (PBS, pH 7.4–8.13 g/L NaCl, 2.87 g/L
Na2HPO4, 0.2 g/L KH2PO4, 0.19 g/L KCl in milliQ water) at room
temperature.
2.3. Plasma lipid analysis
Enzymatic colorimetric assays were used to measure non-fasted
plasma levels of cholesterol and triglycerides (Roche Diagnostics,
Almere, Netherlands) [20]. All assays were performed according to
manufacturer's instructions.
2.4. Skin morphology staining
Paraffin embedded skin sections (4–5 μm) were deparaffinized, re-
hydrated and stained with hematoxylin and eosin according to manu-
facturer's instructions or with toluidine blue. In short, toluidine blue
stock solution (1% w/v in 70% ethanol) was diluted 10 times in NaCl
solution (1% w/v in demi-water). Skin sections were deparaffinized,
rehydrated, stained for 2min with toluidine blue working solution, and
rinsed with demi-water. For both stainings slides were mounted in
Entellan® and the sections were imaged with a Zeiss Axioplan 2 light
microscope (Zeiss, Best, The Netherlands) and BH-2 polarized micro-
scope (Olympus, Leiderdorp, The Netherlands).
2.5. Liquid chromatography-mass spectrometry (LC/MS)
After removing the hypodermis, skin samples were placed overnight
(4 °C) on a paper filter soaked with 0.3% w/v trypsin solution in PBS
(pH 7.4). Next day, the samples were incubated at for 1 h at 37 °C to
isolate the epidermis. Next, the epidermis was rinsed once in 0.1% w/v
trypsin inhibitor in PBS and twice in demi-water. The samples dried at
room temperature and were stored under argon atmosphere for lipids
extraction and FTIR measurements. Epidermal lipids were extracted as
described by Boiten et al. 2016 [21] and the extracts were stored in
chloroform:methanol (2:1; v/v) at 4 °C under argon atmosphere for
cholesterol, CER and FFA analyses.
2.5.1. Cholesterol and CER analysis
Lipid extracts were dried and reconstituted in heptane:-
chloroform:methanol (95:2.5:2.5; v/v/v) to a lipid concentration of
0.3 mg/mL. 5 μL of reconstituted lipid extracts were injected in an
Acquity UPLC H-class system (Waters, Milford, MA, USA) connected to
a triple-quadrupole XEVO TQ-S mass spectrometer (Waters, Milford,
MA, USA). Separation occurred in a normal phase column (PVA-Sil
column: 5 μm particle size, 100×2.1mm i.d., YMC, Kyoto, Japan) at
flow rate of 0.8 mL/min with a gradient solvent shift from 98% heptane
and 2% heptane:isopropanol:ethanol (50:25:25; v/v/v) to 50% heptane
and 50% heptane:isopropanol:ethanol (50:25:25; v/v/v) in 11min
(Supplementary Table S1). The mass spectrometer was coupled to at-
mospheric pressure chemical ionization chamber set to positive ion
mode and the detector measured in full scans from 350 to 1200 amu.
Deuterated CER[NS] (C24deuterated; C18protonated) was added to all
samples as internal standard prior to injection into UPLC/MS. Software
Waters MassLynx 4.1 was used to determine the area under the curve
(AUC) followed by internal standard correction for both cholesterol and
CER analysis. Cholesterol AUC was further corrected for the response
based on a calibration curve of cholesterol and the data was plotted as
absolute amount of cholesterol (μg) per epidermis weight (mg). CER
composition was provided as AUC corrected for the internal standard
and was plotted as relative percentage of ceramide subclasses. CER
subclasses were named as described previously [22] based on different
acyl chains (non-hydroxy fatty acid [N]; α-hydroxy fatty acid [A]; es-
terified ω-hydroxy fatty acid [EO]) and on the sphingoid base (dihy-
drosphingosine, [dS]; sphingosine [S]; phytosphingosine [P]) (Supple-
mentary Fig. S1).
2.5.2. FFA analysis
Lipid extracts were dried and reconstituted in isopropanol to a lipid
concentration of 0.75mg/mL. 2 μL of reconstituted lipid extracts were
injected in the same UPLC-mass spectrometry system described in
Section 2.5.1. Deuterated FFA C18 and FFA C24 were added to all
samples as internal standard. FFA separation in the UPLC H-class
system was done with Purospher Star LiChroCART reverse phase
column (3 μm particle size, 55× 2 mm i.d., Merck, Darmstadt, Ger-
many) with a solvent shift from 100% acetonitrile/milliQ/chloroform/
acetic acid (90:10:2:0.005; v/v/v/v) to 100% methanol/heptane/
chloroform/acetic acid (90:10:2:0.005; v/v/v/v) in 2.5min at a flow
rate of 0.5 mL/min (Supplementary Table S2). The XEVO TQ-S mass
spectrometer was connected to an atmospheric pressure chemical io-
nization chamber (probe temperature: 425 °C, discharge current 3 μA.)
set to negative mode and detector measured in full scan from 200 to
550 amu. Data analysis was performed by Waters MassLynx 4.1 and the
area under the curve (AUC) was corrected by the internal standard FFA
R. Martins Cardoso, et al. BBA - Molecular and Cell Biology of Lipids 1864 (2019) 976–984
977
C24 and corrected for the response based on calibration curves of FFA
C16-C30. Data was plotted as absolute amounts and relative percentage
to the total amount of FFA detected. FFA C16:0 and C18:0 were not
included due to manufacturer's contamination of the chloroform ex-
tracting solvent with these FAs. Unsaturated FFA C16-C18 were plotted
separately as they also are important components of sebum lipids.
2.6. Quantitative real-time PCR (q-PCR)
Total RNA from skin samples without hypodermis were isolated by
guanidinium thiocyanate method [23]. cDNA was synthesized from
1 μg RNA with M-MuLV reverse transcriptase. Quantitative gene ana-
lysis was done with 7500 Fast real-time PCR system (Applied Biosys-
tems, Foster City, CA, USA) using SYBR Green Technology as detection
method. Ribosomal protein, large, P0 (RPL0), cytochrome c-1 (CYC1)
and ribosomal protein S20 (RPS20) were used as housekeeping genes.
Relative gene expression was calculated by deducting the average
threshold cycle (Ct) of the housekeeping genes from the Ct of the target
gene. The difference was then raised to 2 to the power and the data was
plotted as relative fold change compared to the WT control group.
Primer sequences of the analyzed genes are available in Supplementary
Table S3.
2.7. Fourier transform infrared spectroscopy (FTIR)
FTIR measurements were performed with Varian 670-IR spectro-
meter (Agilent Technologies, Inc., Santa Clara, CA) equipped with a
broad-band mercury cadmium telluride detector. Hydrated epidermis
(24 h in 27% NaBr in deuterated water, D2O) was mounted between 2
silver bromide windows for collection of FTIR spectra
(600–4000 cm−1) with resolution of 1 cm−1 in a temperature range
from 0 to 90 °C (0.5 °C/min). Spectra were analyzed and deconvoluted
(half width of 4 cm−1; enhancement factor of 1.7) with Resolutions Pro
4.1 (Varian Inc.) software. CH2 rocking vibrations were used to de-
termine the orthorhombicity of the samples and the transition tem-
perature from orthorhombic to hexagonal phases. The area ratio (peak
area at 730 cm−1/peak area at 719 cm−1) was calculated by curve
fitting the FTIR spectra at 32 °C in the range of CH2 rocking vibrations
(710–740 cm−1). In this range, two peaks were fitted using a Lorentzian
peak function. The transition temperature between the orthorhombic
and hexagonal phases was determined by the disappearance of the peak
at the 730 cm−1. CH2 symmetrical stretching vibrations
(2840–2860 cm−1) were monitored to assess the conformational or-
dering of the lipid chains.
2.8. Transepidermal water loss (TEWL)
The barrier function of the skin of WT and APOE−/− mice was
examined by measuring the transepidermal water loss (TEWL). The
measurements were performed under controlled ambient temperature
(22 °C) and humidity (49.5%). The mice were anesthetized as described
in Section 2.2, their back skin was shaved and the closed-chamber of
the evaporimeter (Aqua Flux AF200, Biox Systems Ltd., London, UK)
was placed on their back skin in upright position perpendicular to the
skin surface. Transepidermal water loss was measured for 90 s.
2.9. Preparation of murine lipid model membranes (mLMM)
Synthetic mLMMs were prepared in a composition representing the
epidermal lipid composition of the WT and the APOE−/− mice. The
membranes contained an equimolar ratio of synthetic CER, FFA and
cholesterol. All mLMM CER mixture were prepared with CER NdS C24,
CER NS C24, CER NP C24, CER AS C24, CER EOS C30 lineolate (40.5:
36:5:14.5:4, respective molar ratios). FFA mixtures were composed of
FFA C16:0, C18:0, C20:0, C20:1, C22:0, C22:1, C24:0, C26:0 in a molar
ratio of 3.5:1.5:2.0:10.0:4.5:3.5:30.0:45.0, representative of WT
epidermis or 4.5:0.5:12.5:31.5:7.5:6.0:22.0:15.50, mimicking lipid
composition of APOE−/− epidermis. mLMM were prepared as described
previously [24]. In short, lipid mixtures (5mg/mL in a 100 μL Hamilton
syringe, Bonaduz, Switzerland) in hexane:ethanol (2:1, v/v) were
sprayed onto a polycarbonate membrane (0.05 μm pore size, 25mm
i.d., Whatmann, Kent, UK) using a Camag Linomat IV with an extended
y-axis arm (Muttenz, Switzerland). Mixtures were sprayed at a 5 μL/min
flow under a gentle nitrogen flow to form a homogenous square (8×8
mm). Afterwards, the membranes were equilibrated at 85 °C for 10min,
cooled down to room temperature and stored in the dark under argon
atmosphere for characterization by X-ray diffraction studies and per-
meability studies.
2.10. X-ray diffraction studies on mLMM
The lamellar and lateral organizations of the mLMM were assessed
by X-ray diffraction measurements performed at the station BM26B of
the European Synchrotron Radiation facility (ESRF, Grenoble, France).
For measurements, mLMM were hydrated for 24 h (27% NaBr in de-
miwater) prior mounting in parallel to the primary beam in a sample
holder with temperature controlled (25 °C). Data were collected with a
Pilatus 1M detector (1043×981 pixels at 172×172 μm spatial re-
solution) for small angle X-ray diffraction (SAXD) and with a Pilatus
300 K (1475×195 pixels at 172× 172 μm spatial resolution) for wide
angle X-ray diffraction (WAXD). SAXD detector was calibrated using
silver behenate (d=5.838 nm) and the WAXD detector was calibrated
using the two strongest reflections of high density polyethylene (HDPE,
d= 0.416 and 0.378 nm). Cholesterol was also used as an internal
standard as it is often a component of our synthetic lipid membranes.
The X-ray wavelength was 0.1034 nm and the sample-to-detector dis-
tances were 1980mm for Pilatus 1M detector and 3110mm to the
Pilatus 300 K detector. Static measurements patterns were collected for
60 s and the scattering intensity I (in arbitrary units) was measured and
calculated as a function of the scattering vector q (in reciprocal nm).
Vector q was defined as q=((4πsin θ) / λ) with θ representing the
scattering angle and λ the wavelength. Using the positions of a se-
quence of equidistant peaks (qn), the periodicity (d-spacing) of a la-
mellar phase was calculated (qn=2nπ / d, n representing the order
number of the diffraction peak). Peaks were integrated in a 40o angle
perpendicular to the sample in the X-ray beam.
2.11. Permeability of mLMM to E-PABA
The barrier function of the murine epidermis lipids was investigated
by the permeability of the mLMM to the model drug ethyl para-ami-
nobenzoic acid (E-PABA; MW: 165.189 g/mol). For the permeation
studies flow through Permegear inline diffusion cells (Bethlehem PA,
USA) were used. mLMM were mounted into the diffusion cells
(0.282 cm2 diffusion area) and hydrated for at least 1 h in the PBS ac-
ceptor phase (pH 7.4, filtered and degassed). The donor phase was a
saturated and filtered E-PABA solution (concentration 0.65mg/mL) in
sodium acetate buffer (pH 5.0; 0.1M acetic acid, 0.1 M sodium acetate,
1:2.5; v/v). To avoid evaporation from the donor phase adhesive tape
was used to close the donor compartment. The acceptor phase was
under constant stirring at 50 rpm perfused and perfused at a flow rate of
2–2.5mL/min. The acceptor phase was sampled every hour for 10.5 h
(Isco Retriever IV; Teledyne Isco, Lincoln NE, USA). The amount of E-
PABA in each sampled fraction was determined by UPLC-UV (Waters,
Etten-Leur, The Netherlands) with a reversed phase C18 column
(Alltima, C-18, 1.7 μm i.d., 2.1× 50mm, Waters, Ireland) at 40 °C and
an UV detector with excitation wavelength at 286 nm. The mobile
phase consisted of acetonitrile with 0.1% trifluoroacetic acid: milliQ
(40:60; v/v) at flow rate of 0.5 mL/min. A calibration curve of E-PABA
in ethanol was also measured. The software TargetLynx was used to
process the data and calculate the flux of E-PABA.
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2.12. Statistical analysis
Statistical analysis was performed using GraphPad Prism 7
(GraphPad Software Inc., CA, USA). Statistically significant differences
between two groups were determined by two-tailed, unpaired Student's
t-tests while differences among three groups were determined using
One- or Two- ANOVAs with Holm-Šídák post-hoc test. Data is presented
as mean ± SD and p values below 0.05 were considered significant.
3. Results
3.1. Deficiency of LDLR or APOE results in (mild) hypercholesterolemia in
chow-fed young adult mice but the skin morphology is preserved
Non-fasted plasma lipid levels were determined by colorimetric
enzymatic assays (Fig. 1a). On chow diet, LDLR−/− mice developed a
mild hypercholesterolemia with increased plasma levels of free cho-
lesterol (0.97 ± 0.15 μg/μL plasma) and cholesteryl esters (CE)
(2.05 ± 0.54 μg/μL plasma) compared to WT controls (free cholesterol
0.36 ± 0.05 μg/μL plasma and 0.97 CE ± 0.15 μg/μL plasma).
APOE−/− mice on the same diet showed severe hypercholesterolemia
marked by 6-fold higher free cholesterol (2.3 ± 0.49 μg/μL plasma)
and 5-fold higher CE (4.59 ± 1.03 μg/μL plasma). Plasma triglycerides
were comparable among WT (1.02 ± 0.15 μg/μL plasma), LDLR−/−
(1.10 ± 0.25 μg/μL plasma), and APOE−/− (1.13 ± 0.16 μg/μL
plasma) mice.
Subsequently, we assessed the impact of hypercholesterolemia on
the skin morphology by hematoxylin and eosin and toluidine blue
stainings (Fig. 1b). Hypercholesterolemic LDLR−/− and APOE−/− mice
displayed a similar skin morphology as the normolipidemic WT controls
with a consistent number of epidermal layers (no hyperproliferation)
and thin SC. In the dermis no striking morphological alterations or signs
of inflammation were observed. Polarized light microscopy on skin
sections did not show the presence of cholesterol crystals in the dermis.
3.2. Increased amounts of shorter and unsaturated FFA species are present
in the epidermis of APOE−/− but not in LDLR−/− mice
To examine whether the skin barrier was affected the three main SC
lipid classes were analyzed by liquid-chromatography mass spectro-
metry (LC/MS). The amount of cholesterol did not differ among groups
(Fig. 2a). Seven CER subclasses (detailed nomenclature as described by
Motta et al. (1993) in Supplementary Fig. S1) were identified in the
murine skin: CER NdS, CER NS, CER NP, CER AdS, CER AS, CER [EO],
the latter representing CER EOdS and CER EOS (Fig. 2b). Abundance of
CER NdS was significantly higher in LDLR−/− and APOE−/− epidermis
(45% compared to 40% for WT controls) while the CER AS was lower in
these mice (9% compared to 16% for WT controls). The average total
CER chain length was 43–44 carbon atoms regardless the genetic
background of the mice (Fig. 2c) and the ratio CER [EO]/CER [non-EO]
both did not change (Supplementary Fig. S2a). CER NP and CER AdS
could not be separated, thus these CERs are reported together re-
presenting about 5% of the total CERs.
Next, FFAs with chain length ranging from 20 to 30 carbon atoms
were analyzed (Fig. 2d and Supplementary Fig. S2b). The epidermal
FFA profile of the severely hypercholesterolemic APOE−/− mice
strongly differed from that observed for the normolipidemic WT control
and mild hypercholesterolemic LDLR−/− mice (Fig. 2d–g). The APOE−/
− epidermis contained 3 times the amount of FFA (Fig. 2e) with a 5-fold
increase in the relative abundance of unsaturated FFA compared to WT
and LDLR−/− epidermis, particularly the levels of FFA C20:1 were in-
creased (Fig. 2d/f). In addition, APOE−/− epidermis showed a shift
towards shorter FFA chains with on average 23 carbon atoms while in
WT and LDLR−/− epidermis this average was around 25 carbon atoms
(Fig. 2g). Over 50% of the FFA species in the APOE−/− epidermis
contained< 24 carbon atoms while for WT and LDLR−/− epidermis
this value was around 20% (Supplement Fig. S2c). In summary, in the
APOE−/− epidermis FFA C20:1 was the most abundant FFA (25%)
followed by FFA C24:0 (21%) and FFA C26:0 (16%) while for WT and
LDLR−/− the most abundant species were FFA C24:0 and FFA C26:0
representing nearly 28% and 40%, respectively. Additionally, the
composition of unsaturated FFAs (C16-C18) was also altered in the
APOE−/− epidermis with marked increase in the amounts of C16:1 (16-
fold), C18:1 (18-fold) and C18:2 (8-fold) compared to the WT control
(Supplement Fig. S2d).
3.3. APOE−/− mice downregulate cholesterol and FFA synthesis genes in
the skin
The epidermal FFA composition of the APOE−/− mice greatly dif-
fered from that of the WT controls. Therefore, the expression of genes
involved in lipid synthesis and uptake from circulation was assessed by
quantitative real-time polymerase chain reaction (q-PCR) and com-
pared to the WT controls to gain insight in the mechanisms underlying
the changes in epidermal barrier lipids of APOE−/− mice (Fig. 3). Ex-
pression of cholesterol synthesis and uptake genes was reduced in the
skin of APOE−/− mice as evidenced by the strong downregulation of
HMGCR and LDLR (Fig. 3a). Expression of ATP-binding cassette genes
(ABCA1, ABCA12, ABCG1) showed no differences between groups
(Supplement Fig. S3a). The expression of CERS3 was not changed while
GBA expression involved in the metabolism of glycolipids in the skin
was downregulated in APOE−/− mice (Fig. 3b). No changes in ex-
pression were observed for CER degradation genes (Supplement Fig.
S3b). Genes involved in FFA synthesis (ACACA) and FFA elongation
(ELOVL1) were remarkably reduced in the APOE−/− mice but no
changes were observed between groups regarding FFA chain desa-
turation (SCD1) (Fig. 3c). Expression of other elongases (ELOVL4,
ELOVL6, ELOVL7) and fatty acid transporters (FABP5, CD36) was not
Fig. 1. Chow-fed young-adult APOE−/− mice develop severe hypercholester-
olemia but their skin shows no morphological changes or signs of inflammation
compared to the chow-fed LDLR−/− mice and WT controls. (a) Plasma levels of
free cholesterol (FC), cholesteryl esters (CE), and triglycerides (TG) were
measured with enzymatic colorimetric assays. Animals were not fasted prior
sacrifice (n= 4–6 animals/group). (b) Hematoxylin and eosin (H&E) and to-
luidine blue (TB) stainings of sections imaged with brightfield microscope
(scale bar= 50 μm; representative images of n= 3 animals/group; *p < 0.05,
**p < 0.01, ****p < 0.0001).
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changed (Supplement Fig. S3c–d). Furthermore, we evaluated whether
the adapted lipid metabolism in the APOE−/− skin could affect kera-
tinocyte proliferation and differentiation markers. However, mRNA
levels of the proliferation marker Ki-67, early differentiation marker
K10, late differentiation markers IVL and FLG did not differ in APOE−/
− skin compared to WT skin (Supplement Fig. S3e). Additionally, the q-
PCR data did not reveal upregulation of pro-inflammatory genes in the
skin of the APOE−/− mice regarding mast cells activation markers
(TPS1, TSP2), pro-inflammatory cytokines (IFNG, TNFA), and macro-
phage marker (CD68) (data not shown).
3.4. Lipids in the epidermis of APOE−/− mice adopt orthorhombic lateral
packing
Changes in the epidermal lipid composition can alter the lateral
organization of these lipids and, consequently, the integrity of the skin
barrier. Therefore, the lateral organization of barrier lipids was de-
termined by Fourier transform infrared spectrometry (FTIR). In all
samples, at low temperatures the lipids had a low conformational dis-
order represented by frequencies below 2850 cm−1 for the CH2 sym-
metric stretching vibrations, which slightly increased with higher
temperatures (Fig. 4a). From 38 °C onwards this gradual shift in fre-
quencies was more pronounced indicating the transition of the lipids
towards the fluid phase (frequencies above 2852 cm−1). Throughout
this transition the lipids in the APOE−/− epidermis showed slightly
higher vibration frequencies than that of the lipids in epidermis of WT
mice. The CH2 rocking vibrations at 32 °C (skin temperature) showed an
orthorhombic lateral packing in a fraction of the lipids represented by
the presence of a doublet: a strong peak at 719 cm−1 and a weaker peak
Fig. 2. APOE−/− mice show remarkably
altered epidermal FFA profile compared to
WT and LDLR−/− mice, while cholesterol
and ceramides are not/minimally affected.
LC/MS analysis of the three main classes of
SC lipids: (a) cholesterol, (b–c) CERs, (d–g)
FFAs. CER data was plotted as a percentage
of the total peak area after correction by
internal standard. Nomenclature of cer-
amides subclasses based on different acyl
chains (non-hydroxy fatty acid [N]; α-hy-
droxy fatty acid [A]; esterified ω-hydroxy
fatty acid [EO]) and on the sphingoid base
(dihydrosphingosine, [dS]; sphingosine [S];
phytosphingosine [P]). CER[EO] represents
CER EOS and CER EOdS (n=3/group;
*p < 0.05; **p < 0.01; ***p < 0.001;
****p < 0.0001).
Fig. 3. Downregulated mRNA expression of cholesterol, CER and FFA synthesis
genes in the skin of hypercholesterolemic APOE−/− mice. The expression of
genes encoding for key proteins and enzymes involved in (a) cholesterol, (b)
ceramide and (c) fatty acid synthesis were measured: HMG-CoA reductase
(HMGCR), LDL receptor (LDLR), ceramide synthase 3 (CERS3), glucocer-
ebrosidase (GBA), acetyl-Coenzyme A carboxylase alpha (ACACA), fatty acid
synthase (FAS), elongation of very long chain 1 (ELOVL1), stearoyl-Coenzyme A
desaturase 1 (SCD1) (*p < 0.05, ** p < 0.01).
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at 730 cm−1 (Fig. 4b). The fraction of lipids in an orthorhombic packing
is comparable between groups as the area ratio of the two peaks was
similar for all samples (Fig. 4c). Transition temperature from orthor-
hombic to hexagonal phases was determined by the disappearance of
the peak at 730 cm−1 and it was not different between groups, varying
from 40 to 44 °C (Supplement Fig. S4).
3.5. Altered FFA profile in the APOE−/− epidermis increases TEWL in vivo
and the permeability in murine lipid model membranes (mLMM)
To examine whether the changes in FFA composition observed in
the APOE−/− epidermis impair skin barrier function, the TEWL (water
loss from the skin) of both WT and APOE−/− mice was measured. The
TEWL of APOE−/− mice was significantly higher (12.9 ± 0.5 g/m2 h)
than that observed for the WT control (10.9 ± 0.6 g/m2 h) (p < 0.01).
To further study whether the lipid barrier and in particular the changes
in FFA composition contributed to the impaired skin barrier function,
permeation studies were performed using mLMMs. The mLMMs had a
fixed CER composition, but a FFA composition mimicking that in the
WT epidermis (WTLMM) or in the APOE−/− epidermis (APOE−/−LMM ). The
lamellar and lateral lipid organizations of the mLMMs were character-
ized by small- and wide-angle X-ray diffraction studies. The lipids in
both WTLMM and APOE−/−LMM assembled in long and short periodicity
phases with no differences in the repeated distances (Fig. 5b). In the
APOE−/−LMM fewer lipids adopted an orthorhombic lateral packing com-
pared to the WTLMM as seen by the lower peak with 0.378 nm spacing in
the wide-angle X-ray diffraction (Fig. 5c).
To assess the functionality of the barrier E-PABA, a commonly used
topical anesthetic, was chosen as model drug for the permeability stu-
dies. A steady state flux of E-PABA was achieved in approximately 3 h
for both types of mLMM (Fig. 5d) with significantly increased flux
through the APOE−/−LMM in comparison to the WTLMM (40 ± 3.3 v.s.
14 ± 2.2 μg/cm2/h) (Fig. 5e). After diffusion, analysis of the donor and
the collected acceptor solution showed nearly 100% drug recovery in
both groups (data not shown).
4. Discussion
In this study we showed for the first time that severe systemic hy-
percholesterolemia associated with apoE deficiency in young adult
Fig. 4. Altered epidermis FFA composition does not modify the orthorhombic
lateral lipid organization in the skin APOE−/− mice. FTIR was used to de-
termine the lateral packing of lipids in the epidermis of WT and APOE−/− mice.
(a) CH2 symmetric stretching vibrations (2848–2856 cm−1) were plotted
against temperature (0–90 °C) to follow the phase transition of the lipids; (b)
CH2 rocking vibrations (710–740 cm−1) plotted at skin temperature (32 °C); (c)
ratio between peak area at 730 cm−1 and peak area at 719 cm−1 (32 °C).
Fig. 5. Skin of APOE−/− mice shows higher transpepidermal water loss (TEWL)
than WT control in vivo and epidermal lipid composition of APOELMM−/− mice
shows remarkable increase in lipid barrier permeability to ethyl para-amino-
benzoic acid (E-PABA). (a) Average TEWL at the skin surface of WT and
APOE−/− mice. Data was collected for 90 s in vivo using a close-chamber
evaporimeter. (b) Lamellar and (c) lateral organizations of murine lipid model
membranes (mLMM) representing the epidermal lipids of the WT and APOE−/−
mice determined by small angle- and wide angle X-ray diffraction, respectively.
In Arabic numbers (1–3) the long periodicity phase orders, in Roman numbers
(I–II) the short periodicity phase orders. Asterisk indicates the reflection of
crystalline cholesterol. E-PABA flux through WTLMM ( ) and APOE−/−LMM ( ) (d)
over time (10.5 h) and (e) on steady state (average). Data represents three
different experiments (n= 6–7/group) (**p < 0.01; ****p < 0.0001).
R. Martins Cardoso, et al. BBA - Molecular and Cell Biology of Lipids 1864 (2019) 976–984
981
mice affects the lipid composition and barrier function of the epidermis,
while in LDLR deficiency with mild hypercholesterolemia the epidermis
was not affected. Here, we focused on chow diet fed and young adult
mice to specifically investigate the effects of mild and severe hy-
percholesterolemia on barrier lipid composition and function.
Analysis of the epidermal lipid composition showed comparable
levels of cholesterol in the APOE−/− epidermis compared to the WT
controls despite the significant increase in circulating cholesterol [8,9].
Previous in vitro studies repoted downregulation of HMGCS1 [25] and
suppression of the de novo cholesterol synthesis [26] in keratinocytes
upon increased uptake of 25-hydroxycholesterol by these cells. In line,
based on the q-PCR data a higher cholesterol uptake from the circula-
tion is expected in the skin of APOE−/− mice and cholesterol home-
ostasis is likely maintained by local reduction of cholesterol synthesis
(HMGCR) and uptake from the circulation (LDLR).
FFAs and CERs share a common biosynthetic pathway in the epi-
dermis and alterations in the FFA chain length or unsaturation translate
into similar trends in the CER profile [27,28]. Conversely, in our study
the remarkable levels of unsaturared and short chain FFAs in the
APOE−/− epidermis were not associated with similar alterations in the
CER unsaturation and chain length profiles. This suggests that the ob-
served changes in the FFAs may not be related to local biosynthesis,
which is supported by the reduced expression of genes involved in FFA
synthesis and elongation (ACACA and ELOVL1) in the APOE−/− epi-
dermis. ELOVL1 is the main enzyme responsible for elongation of FA
C20-C24 with especially high activity towards saturated and un-
saturated FA C20-C22 [29]. ELOVL1 activity can be inhibited in vitro by
FA C18:1 in a dose-dependent manner [30]. Similar to the epidermis of
APOE−/− mice, in ELOVL1−/− mice the abundance of FFA and CER
containing FA≥ C26 was strongly reduced with lower elongation ac-
tivity towards FA C20-C22-CoA [27]. Despite the increased percentage
of unsaturated FFA in the skin of APOE-/- mice, no changes were ob-
served in mRNA levels of SCD1, a gene encoding for the rate-limiting
enzyme in the desaturation of FFA [31]. However, SCD1 expression is
strictly regulated in both gene and protein levels, usually showing a fast
turn off; thus, further differences should be evaluated in protein and
enzyme activity levels [32,33].
Altogether, our LC/MS and q-PCR data suggests an increased flux of
both cholesterol and FFA from the plasma into the skin of APOE−/−
mice. In the plasma, cholesterol is mainly transported as CE in the core
of lipoproteins. After cellular uptake, the CE-rich core of the lipoprotein
remnants is metabolized into free cholesterol and FA. In mice, plasma
CE is mostly formed by esterification of cholesterol with unsaturated FA
and LC/MS/MS analysis of hypercholesterolemic APOE−/− plasma
shows> 2-fold higher levels of FA C18:1-derived CE compared to the
normolipidemic WT mice [7]. Similar to the plasma, increased amounts
of FA C18:1 but also FA C18:2, an essential FA, were detected in the
epidermis of APOE−/− mice. Interestingly, in vitro studies showed that
the incubation of HaCaT keratinocytes with FA C18:1 increased the
mRNA levels of HMGCS1 and the activity of HMGCoA synthase pro-
moter. However, incubation of these cells simultaneously with FA
C18:1 and 25-hydroxy cholesterol resulted in downregulation of sterol
synthesis [25]. Thus, it is possible that a higher uptake of CE-rich li-
poproteins by keratinocytes of APOE−/− mice leads (1) to activation of
compensatory feedback regulation in local lipid synthesis, at least on
mRNA level, and (2) to the incorporation of FFAs derived from the CE-
rich particles into the SC lipid matrix.
Modifications of skin lipid content and morphology have been
previously described using other hyperlipidemic mouse models
[8–10,34]. These modifications were mostly analyzed in double-
knockout mice on LDLR−/− or APOE−/− backgrounds; in which two
opposite effects occur: (1) hyperlipidemia by impaired (V)LDL pathway
and (2) hypolipidemia by impaired high-density lipoprotein pathway.
In these studies, double-knockout mice generated on LDLR−/− back-
ground (mild hyperlipidemic model) developed skin free cholesterol
and CE accumulation, and inflammation in association with a high
cholesterol/high fat diets but not on chow diet. In contrast, the double-
knockout with APOE−/− background (severe hyperlipidemic model)
developed these alterations spontaneously in time. Thus, in line with
our results this indicates that the severity of the hypercholesterolemia
of the genetic background plays an important role in the development
of the skin phenotypes.
Nonetheless, it is important to note that apoE and the LDLR are
expressed in murine skin [18,35–37]. The role of apoE in the skin re-
mains to be elucidated, but the role of LDLR as a mediator for the up-
take of lipoproteins by the skin has been described [35]. Thus, the
absence of these proteins/receptors in the skin of our mouse models
may contribute to the changes reported in this study. Although CE le-
vels are elevated in the plasma of LDLR−/− mice as compared to WT
controls, the epidermal lipid profile is not affected in the skin of these
mice. In this line, it could be hypothesized that LDLR deficiency in the
skin of these mice prevented the accumulation of the CE-derived lipids.
Additionally, considering the hypercholesterolemia as the driving
factor altering the composition of the epidermal lipids, LDLR−/− mice
on chow diet develop only a minor hypercholesterolemic phenotype
[11], which in turn could have led to lower skin lipoprotein accumu-
lation. In this view, skin-specific deletion of lipid transporters (e.g.
LDLR, CD36) on a WT and on an APOE−/− background may help
elucidate the mechanisms underlying this plasma-skin lipid crosstalk.
Studies using lipid model membranes or diseased skin reported that
elevated FFA content increases the fraction of lipids assembled in an
orthorhombic packing [28,38]. In contrast, shorter chain lengths and/
or higher degree of unsaturation of FFA species also in the presence of
the same CER composition favors a hexagonal packing and higher
permeability of the lipid barrier [24,39]. As all these changes are pre-
sent in the APOE−/− epidermis, these opposite effects may counteract
maintaining the dense lipid orthorhombic organization. However,
when interpreting FTIR results one must remember that not only cho-
lesterol, CERs and FFAs are present on the skin surface; and these vi-
brations are influenced by other lipid species; e.g. sebum lipids, which
are abundantly present in mouse skin [40–42].
Direct ex vivo analysis of SC barrier function in non-nude mice is
limited by the high density of hair follicles, which hinders the isolation
of the few SC layers or the intact viable epidermis. Additionally, the
high number of hair follicles offers an additional route of permeation
for model drugs when studying skin barrier integrity [43,44]. TEWL is a
well-established method to monitor the water loss from the skin and to
assess the functionality of the SC barrier [45,46]. An increase in TEWL
values, as seen for the skin of the APOE−/− mice, has been strongly
correlated with a reduced chain length of the FFAs and CERs in the SC,
emphasizing the importance of SC lipids for the skin barrier function
[28].
mLMMs were used as SC substitutes to assess the contribution of the
APOE−/− epidermal lipid composition to the impairment of the skin
barrier function. Higher degree of unsaturation of the FFAs correlates
with a lower the fraction of lipids forming an orthorhombic packing in
the SC or lipid model membranes [24,28], while an increased abun-
dance of short chain FFAs may, already at low levels, shows higher
mobility in lipid model membranes. Both alterations in FFA profile are
associated with a great increase in the permeability of the lipid model
membrane to E-PABA [47]. In agreement, the altered FFA composition
of APOE−/− epidermis resulted in higher permeability to E-PABA
through APOE−/−LMM compared to WTLMM. Our mLMMs comprised 5%
of FFA C16-C18 as we aimed to study the differences in permeability
associated with epidermal barriers lipids. Higher levels of these short
chain FFAs would only further increase the permeability of the APOE−/
−
LMM, especially considering that unsaturated FFA C16-C18 are higher
in the APOE−/− epidermis.
In conclusion, we show that the hypercholesterolemia in young
adult APOE−/− mice affects the skin lipid composition and is associated
with a compromised lipid barrier function. The severity of the hy-
percholesterolemia and plasma CE levels may play critical roles in the
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development of this skin phenotype. This highlights the relevance of
investigating the composition and functionality of the skin barrier of
hypercholesterolemic patients at young age and prior the development
of inflammatory processes as to our knowledge this information is not
yet available. In turn, it may be possible to protect the skin of these
patients and prevent future development of skin inflammatory pheno-
types.
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